Rebekah Pennington (Becky Pennington)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Smoking Cessation

Diffusion Weighted Imaging

Randomized Controlled Trial

Top Venues

PharmacoEconomics

Health technology assessment (Winchester, England)

Applied health economics and health policy

Medical decision making : an international journal of the Society for Medical Decision Making

This page only lists publications with an associated author ORCID identifier.

Publications

Rebekah Pennington, Hareth Al-Janabi
Modelling Informal Carers' Health-Related Quality of Life: Challenges for Economic Evaluation. Applied health economics and health policy (2023)
David John Mott, Hannah Schirrmacher, Hareth Al-Janabi, Sophie Guest, Rebekah Pennington, Nicolas Scheuer, Koonal Kirit Shah, Christopher Skedgel
Modelling Spillover Effects on Informal Carers: The Carer QALY Trap. PharmacoEconomics (2023)
Rebekah Pennington, Jack Eaton, Anthony James Hatswell, Helen Taylor
Carers' Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations. PharmacoEconomics 40 (9) (2022)
Philip Hykin, Andrew Toby Prevost, Sobha Sivaprasad, Joana C Vasconcelos, Caroline Murphy, Joanna Kelly, Jayashree Ramu, Abualbishr Alshreef, Laura Flight, Rebekah Pennington, Barry Hounsome, Ellen Lever, Andrew Metry, Edith Poku, Yit C Yang, Simon Peter Harding, Andrew John Lotery, Usha Chakravarthy, John E Brazier
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health technology assessment (Winchester, England) 25 (38) (2021)
Rebekah Pennington, Abualbishr Alshreef, Laura Flight, Andrew Metry, Edith Poku, Philip Hykin, Sobha Sivaprasad, Andrew Toby Prevost, Joana C Vasconcelos, Caroline Murphy, Joanna Kelly, Yit Yang, Andrew John Lotery, Michael Williams, John Brazier
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study. PharmacoEconomics 39 (8) (2021)
Gemma Elizabeth Shields, Rebekah Pennington, Ash Bullement, Stuart James Wright, Jamie Elvidge
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time. PharmacoEconomics (2021)
Rebekah Pennington, Shije Ren, Samantha Barton, Mariana Bacelar, Steven J Edwards
Dinutuximab Beta for Treating Neuroblastoma: An Evidence Review Group and Decision Support Unit Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 37 (8) (2020)
Paul D Griffiths, Michael Bradburn, Michael Joseph Campbell, Cindy L Cooper, Nicholas D Embleton, Ruth Graham, Anthony Richard Hart, Deborah A Jarvis, Mark David Kilby, Mabel Leng Sim Lie, Gerald Mason, Laura Mandefield, Cara Mooney, Rebekah Pennington, Stephen Courtenay Robson, Allan Wailoo
MRI in the diagnosis of fetal developmental brain abnormalities: the MERIDIAN diagnostic accuracy study. Health technology assessment (Winchester, England) 23 (49) (2020)
Rebekah Pennington, Monica Hernandez-Alava, Stephen Pudney, Allan Wailoo
The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals. PharmacoEconomics 37 (1) (2020)
Susan Griffin, James Love-Koh, Rebekah Pennington, Lesley Owen
Evaluation of Intervention Impact on Health Inequality for Resource Allocation. Medical decision making : an international journal of the Society for Medical Decision Making 39 (3) (2019)
Rebekah Pennington, Alex Filby, Lesley Owen, Matthew Taylor
Smoking Cessation: A Comparison of Two Model Structures. PharmacoEconomics 36 (9) (2019)